Skip to search formSkip to main contentSkip to account menu

Aluminum Hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable]

Known as: Gavsicon Regular Strength (aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG) Chewable Tablet, ALUMINUM HYDROXIDE 80 mg / MAGNESIUM TRISILICATE 14.2 mg ORAL TABLET, CHEWABLE [Gaviscon Regular Strength], Gaviscon Chewable 80/14.2 Chewable Tablet 
National Institutes of Health

Related topics

Related topics

9 relations
Aluminum HydroxideCALCIUM STEARATEChewable TabletMagnesium Cation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux
ObjectivesManagement of laryngopharyngeal reflux (LPR) typically comprises alginates and proton pump inhibitors (PPIs) alone or… 
2018
2018
Anaphylaxie à l’alginate de sodium du Gaviscon®
2017
2017
A New Approach to Enhance Bioavailability : Dosage Forms with Extended Residence Time in the Stomach
In recent years there has been an increase in studies aiming to enhance bioavailability by extending the residence time of active… 
2016
2016
Role of vitamin D3 combined to alginates in preventing acid and oxidative injury in cultured gastric epithelial cells
BackgroundGastric diseases are a worldwide problem in modern society, as reported in the USA, in the range of 0.5–2 episodes/year… 
Highly Cited
2012
Highly Cited
2012
Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
BackgroundMedical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this… 
2010
2010
PA26 NO EFFECT OF SODIUM ALGINATE (GAVISCON®) ON APNOEA OF PREMATURITY INDUCED BY GASTRO-OESOPHAGEAL REFLUX
Highly Cited
2009
Highly Cited
2009
The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux
Laryngopharyngeal reflux (LPR) refers to the backflow of stomach contents into the laryngopharynx. Increasing evidence has… 
1992
1992
Alginic acid decreases postprandial upright gastroesophageal reflux
This study tested the hypothesis that (alginic) acid may have a preferential effect on reflux in the upright position. We… 
Highly Cited
1990
Highly Cited
1990
Investigation into the Barrier Action of an Alginate Gastric Reflux Suppressant, Liquid Gaviscon®
SummaryThe barrier properties of an alginate antireflux agent (Liquid Gaviscon®, Reckitt and Colman, UK) were investigated using… 
1982
1982
[Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)